ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 112846 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 112846; 2) Community: the network communities that were significantly associated with the response to NSC 112846; 3) Molecule: the relationships between components within communities and NSC 112846; 4) MDR: the compounds that were significantly associated with the NSC 112846.

NSC Compound Enrichment Correlation
NSC 376739 5,12-Naphthacenedione, 10-[(2,6-dideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- 0.00423163567577551 0.32516424
NSC 639977 Null 0.00423163567577551 0.27499487
NSC 654378 Null 0.00423163567577551 0.22424202
NSC 654509 Pirarubicin HCl 0.00423163567577551 0.29383955
NSC 670226 trans-2((1-(4-fluorphenyl-methyl)-4-tert.butylcyclohexyl)oxy)N,N-dimethyl-1-ethanamine-, salt with fumaric acid 0.00423163567577551 0.054016888
NSC 675967 Null 0.00423163567577551 0.38910116
NSC 708423 Null 0.00423163567577551 0.26211646
NSC 721049 7Z-Plakortide H 0.00423163567577551 0.30022734
NSC 758423 Amsacrine (USAN) 0.00423163567577551 0.339104
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.00423163567577551 0.39521542
Total:98  Current:19    [First] [Prev] [Next] [Last]